Skip to the reading

LiraglutideCare cards

Liraglutide questions to take along

Know when to pause

If the answers clash, stop and ask why.

The pitch may be smooth. The answers still need to be plain, specific, and checkable.

What to check

  • A prescription medicine with no prescription check.

    Handing over a prescription drug without a licensed prescriber’s order violates federal law, as of September 26, 2026.

  • A form that ends the conversation.

    Under national medical board guidance, care cannot rest solely on a fixed checklist that gathers too little health information.

    Whoever reviews the form needs ways to follow up with questions or gather more health history if needed.

    The national guidance is advice; the person treating you must follow your state’s rules.

    Ask who reads the form and how they can ask you follow-up questions.

  • Nobody available when a question comes up.

    The FDA, the U.S. agency that reviews medicines, warns about services that leave you without a licensed doctor to answer questions once the medicine arrives.

  • Made-to-order medicine described as approved.

    Calling a compounded drug FDA-approved is not truthful, according to FDA as of September 26, 2026.

A note before moving on

Price alone is a weak test

FDA warns that implausibly cheap offers may be a concern. A lower price for an approved copy or for paying without insurance does not prove a problem.

There is no single dollar cut-off here. Compare written quotes for the same medicine, amount, and included services. A brand’s list price alone is not that comparison.

Check the pharmacy’s licence, who reviews your health, and who answers questions afterward. Ask why an unusually low quote costs less and what it leaves out.

Open the record

Read this for the detail

Next reading card

Ask about compounding